Results 311 to 320 of about 1,457,300 (387)

Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients with Systemic Lupus Erythematosus: A Multicenter, Open‐Label Trial

open access: yesArthritis Care &Research, Accepted Article.
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; NCT04179032) used three‐weight‐band ...
Hermine I. Brunner   +14 more
wiley   +1 more source

Anti-mitochondrial M2 antibody links to cardiac involvement and immune-mediated inflammatory myopathy-like pathology in myositis. [PDF]

open access: yesRheumatology (Oxford)
Pang Y   +19 more
europepmc   +1 more source

Efficacy and safety of Janus kinase 1/2 inhibitor KL130008 in active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase II trial. [PDF]

open access: yesBMC Med
Cheng Y   +31 more
europepmc   +1 more source

Malaria Immunology

open access: yesRevista do Instituto de Medicina Tropical de São Paulo, 2002
PERLMANN P., TROYE-BLOMBERG M.
doaj  

Correction: Polysialic acid restrains inflammatory monocyte maturation. [PDF]

open access: yesFront Immunol
Passos I   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy